Pregnancy :: Hair samples show babies exposure to ‘crystal meth’ – a Canada study

Methamphetamine (MA) abuse is a serious health problem of epidemic proportions. Exposure to this drug, particularly during pregnancy, is difficult to ascertain. Sparse information on gestational exposure is available. Crystal meth boosts alertness and promotes a sense of wellbeing, euphoria, and exhilaration. It also curbs appetite and enhances sexual arousal. But long term abuse damages nerves in the brain and can lead to psychotic behaviour and aggression.

Flu :: Americans willing to make changes in their lives

In the case of an outbreak of pandemic flu, large majority of Americans willing to make major changes in their lives. Survey also finds many people would face critical work-related problems. The latest national survey conducted by the Harvard School of Public Health (HSPH) Project on the Public and Biological Security finds that when faced with a serious outbreak of pandemic flu, a large majority of Americans are willing to make major changes in their lives and cooperate with public health officials’ recommendations.

Flu :: Australia ready for avian influenza or bird flu – Tony Abbott

The results of a massive health simulation conducted this week will be studied to improve Australia’s response to any future disease outbreak, Health Minister Tony Abbott says. More than 1,000 state and federal government officials took part in the $4.1 million exercise to test how prepared Australia is for an outbreak of avian influenza, or bird flu.

Diabetes :: Merck KGaA & Glenmark Pharmaceuticals Collaboration on DPPIV Inhibitor for Type 2 Diabetes

Merck KGaA and Glenmark Pharmaceuticals S.A (Switzerland), a wholly owned subsidiary of Glenmark Pharmaceuticals India (GPL), have entered into an agreement for Glenmark?s DPPIV inhibitor GRC 8200, a treatment for type 2 diabetes in Phase II of clinical development. The transaction is expected to close this year upon approval of the exclusive license to GRC 8200 by the U.S. anti-trust agencies under the HSR Act.

Obesity :: Manhattan pharmaceuticals – oral oleoyl-estrone clinical program to include morbidly obese

Manhattan Pharmaceuticals, Inc. (Amex: MHA) today announced expansion of its oral Oleoyl-estrone (OE) clinical obesity program to include the morbidly obese. A new US Phase 2a clinical trial evaluating oral OE in morbidly obese male subjects will be initiated in October 2006. The morbidly obese population in the US is estimated to be 14 million people. OE is the Company’s orally administered product candidate in development for the treatment of obesity.

Chikungunya :: Treating after effects of chikungunya

Chikungunya is turning out to be a national epidemic & a major calamity. There are horror stories of whole villages in Rajasthan being affected & old people who are so debilitated that they are not able to feed themselves.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack